牛牛AI助理已提取核心訊息
Joaquin Duato, CEO and Chairman of the Board of Johnson & Johnson, has engaged in a transaction involving the company's stock on February 15, 2024. The specific details of the transaction, such as the number of shares traded, the nature of the shares, the transaction price, and the total value of the shares, were not disclosed in the announcement. This financial activity is of interest to investors who closely monitor insider transactions as indicators of the company's performance and management's confidence in the firm's future.
Joaquin Duato, CEO and Chairman of the Board of Johnson & Johnson, has engaged in a transaction involving the company's stock on February 15, 2024. The specific details of the transaction, such as the number of shares traded, the nature of the shares, the transaction price, and the total value of the shares, were not disclosed in the announcement. This financial activity is of interest to investors who closely monitor insider transactions as indicators of the company's performance and management's confidence in the firm's future.
強生公司首席執行官兼董事會主席華金·杜阿託於2024年2月15日參與了一項涉及公司股票的交易。公告中沒有披露交易的具體細節，例如交易的股票數量、股票的性質、交易價格和股票的總價值。這種財務活動引起了投資者感興趣，他們密切關注內幕交易，以此作爲公司業績和管理層對公司未來的信心的指標。
強生公司首席執行官兼董事會主席華金·杜阿託於2024年2月15日參與了一項涉及公司股票的交易。公告中沒有披露交易的具體細節，例如交易的股票數量、股票的性質、交易價格和股票的總價值。這種財務活動引起了投資者感興趣，他們密切關注內幕交易，以此作爲公司業績和管理層對公司未來的信心的指標。
有用
沒用
該公告為獨立文件：